SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-13-064352
Filing Date
2013-11-26
Accepted
2013-11-26 16:27:36
Documents
1
Period of Report
2013-12-17
Effectiveness Date
2013-11-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A v361420_def14a.htm DEF 14A 270482
  Complete submission text file 0001144204-13-064352.txt   271651
Mailing Address 86 GLOUCESTER PLACE GROUND FLOOR SUITE LONDON X0 W1U 6HP
Business Address 86 GLOUCESTER PLACE GROUND FLOOR SUITE LONDON X0 W1U 6HP 44 (0) 203 617 8739
Lightlake Therapeutics Inc. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: DEF 14A | Act: 34 | File No.: 333-139915 | Film No.: 131244509
SIC: 1000 Metal Mining